Plunkett Research Online: Endonovo Therapeutics Inc

ENDONOVO THERAPEUTICS INC (ENDV:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Provides management & commercialization services.....

Endonovo Therapeutics Inc
Ticker: ENDV
Exchange: PINX
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 800 489-4774
Fax: 818 880-4777
Address: 6320 Canoga Avenue
15th Floor
Woodland Hills, CA 91367 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Sales Financing
Contacts Description

Alan Collier CEO/CFO/Chief Accounting Officer/Director/Secretary
Michael Mann President
See More

Auditor: Rose, Snyder & Jacobs LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: